申请人:Hoffmann-La Roche Inc.
公开号:US08349893B2
公开(公告)日:2013-01-08
This invention relates to novel 4-trimethylammoniobutyrates of the formula
wherein A1, R1, m and n are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds inhibit carnitine palmitoyl transferase (CPT) activity, in particular CPT2 activity, and can be used as medicaments.
本发明涉及新颖的4-三甲基氨基丁酸盐,其化学式为A1,R1,m和n如所述和要求中定义的那样,以及它们的药学上可接受的盐。这些化合物抑制肉碱棕榈酰转移酶(CPT)活性,特别是CPT2活性,并可用作药物。